LECTURE 21 Subgroup Analysis “Fun to look at but don’t believe them!” (P Sleight, 2000) Deciding on analysis after looking at the data is “dangerous, useful, and…

Laura Mucci, Pharm.D. Candidate Mercer University 2012 Preceptor: Dr. Rahimi February 2012 Limited data available for use of statins for primary prevention of cardiovascular…

Enoxaparin – Future Prospects in Cardiovascular Diseases David Hasdai, MD Rabin Medical Center Tel Aviv University TIMI 8 BAT GUSTO IIA OASIS Pilot TIMI 7 CURE CAPRIE CREDO…

Benefits and adverse events in younger (age Abstract Background Limited data exists regarding outcomes and AT benefit/toxicity in Y pts with stage II and III CC. We examined…

Laura Mucci, Pharm.D. Candidate Mercer University 2012 Preceptor: Dr. Rahimi February 2012 Limited data available for use of statins for primary prevention of cardiovascular…

Slide 1 Chapter 15 Prepared by Samantha Gaies, M.A. 1 Let’s start with an example … A high school gym instructor would like to test the effectiveness of a behavior modification…

Enoxaparin – Future Prospects in Cardiovascular Diseases David Hasdai, MD Rabin Medical Center Tel Aviv University TIMI 8 BAT GUSTO IIA OASIS Pilot TIMI 7 CURE CAPRIE CREDO…

SEEING IS BELIEVING: Telling stories with statistics – in pictures. We’re failing. Do you see the same thing here?. This is your brain on statistics. The total sample…

Staff Update: Special Education, High Ability, RtI, Policy Manual February, 2009 Response to Intervention - Paradigm Change We cannot start by assuming the problem is with…